EUVIMEDEUVIMED entdecken
Crossref

Mechanistic Insights Into METTL1/WDR4‐Mediated m7G Modification in Prostate Cancer Progression and Its Potential as a Therapeutic Target

Wangdong Deng, Shanming Lu, Guodong Ding, Hanliang Zhu, Yiwen Chen, Yuantang Zhong, Zuomin Wang iD

Journal of Biochemical and Molecular Toxicology · 2025-11 · 39 (11)

DOI: 10.1002/jbt.70546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 16.10.2025. Verfasst von Wangdong Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Longgang District Central Hospital of Shenzhen, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: This study is supported by Key Medical Discipline in Longgang District and Research personnel training program of Longgang Central Hospital..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N7‐methylguanosine (m7G) represents a critical posttranscriptional modification linked to oncogenesis, but its involvement in prostate cancer (PCa) remains unclear. This study focuses on WD repeat domain 4 (WDR4) and methyltransferase like 1 (METTL1) to explore their function and therapeutic potential in PCa. Using qRT‐PCR, Western blot, m7G RNA immunoprecipitation (MeRIP), and functional assays (CCK‐8, Transwell, TUNEL), we investigated how METTL1/WDR4 regulate m7G modification, the PI3K/AKT/mTOR cascade, and target genes (MYC and VEGF), as well as their impact on DU145 cell growth, motility, invasion, and apoptosis. Both METTL1 and WDR4 were highly expressed in PCa samples and DU145 cells, correlated with elevated m7G tRNA modification levels. Their knockdown markedly inhibited DU145 cell growth, motility, and invasion, and facilitated apoptosis. These effects were associated with reduced m7G modification, suppression of the PI3K/AKT/mTOR pathway, and downregulation of MYC and VEGF expression, showing synergistic inhibitory effects. This study reveals that METTL1 and WDR4 are overexpressed in PCa and that, in DU145 cells, their knockdown was associated with suppressed m7G modification and attenuated oncogenic phenotypes. These model‐specific findings suggest that METTL1/WDR4 may represent potential therapeutic targets in prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMethyltransferasesHumansMaleCell Line, TumorCell ProliferationDisease ProgressionApoptosisPhosphatidylinositol 3-KinasesCell MovementSignal TransductionTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

METTL1PI3K/AKT/mTOR signaling pathwayWDR4m7G modificationprostate cancer

Substanzen

MethyltransferasesMETTL1 protein, humanPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Urology, Longgang District Central Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Department of Pathology, Longgang District Central Hospital of Shenzhen, Shenzhen, China.

ORCID-Profile: Zuomin Wang

Förderung

  • This study is supported by Key Medical Discipline in Longgang District and Research personnel training program of Longgang Central Hospital.

Zitieren

APA

Deng, W., Lu, S., Ding, G., Zhu, H., Chen, Y., Zhong, Y., & Wang, Z. (2025). Mechanistic Insights Into METTL1/WDR4‐Mediated m7G Modification in Prostate Cancer Progression and Its Potential as a Therapeutic Target. Journal of Biochemical and Molecular Toxicology, 39(11). https://doi.org/10.1002/jbt.70546

Vancouver

Deng W, Lu S, Ding G, Zhu H, Chen Y, Zhong Y, et al. Mechanistic Insights Into METTL1/WDR4‐Mediated m7G Modification in Prostate Cancer Progression and Its Potential as a Therapeutic Target. Journal of Biochemical and Molecular Toxicology. 2025;39(11). doi:10.1002/jbt.70546

BibTeX
@article{Deng2025,
  author = {Deng, Wangdong and Lu, Shanming and Ding, Guodong and Zhu, Hanliang and Chen, Yiwen and Zhong, Yuantang and Wang, Zuomin},
  title = {Mechanistic Insights Into METTL1/WDR4‐Mediated m7G Modification in Prostate Cancer Progression and Its Potential as a Therapeutic Target},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {11},
  doi = {10.1002/jbt.70546}
}
Kostenlos starten →